Paraoxonase gene mutations in amyotrophic lateral sclerosis

Annals of Neurology

Volumn 68, Issue 1, 2010, Pages 102-107

  Ticozzi, Nicola ^a,b   LeClerc, Ashley Lyn ^a   Keagle, Pamela J ^a   Glass, Jonathan D ^c   Wills, Anne Marie ^d   Van Blitterswijk, Marka ^a   Bosco, Daryl A ^a   Rodriguez Leyva, Ildefonso ^e   Gellera, Cinzia ^f   Ratti, Antonia ^b   Taroni, Franco ^f   McKenna Yasek, Diane ^a   Sapp, Peter C ^a,g,h   Silani, Vincenzo ^b   Furlong, Clement E ^i,j   Brown Jr , Robert H ^a   Landers, John E ^a  

^a UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF MILAN   (Italy)

^c EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d MASSACHUSETTS GENERAL HOSPITAL   (United States)

^e UNIVERSIDAD AUTÓNOMA DE SAN LUIS POTOSÍ   (Mexico)

^f DEPARTMENT OF NEUROSURGERY   (Italy)

^g HOWARD HUGHES MEDICAL INSTITUTE   (United States)

^h MASSACHUSETTS INSTITUTE OF TECHNOLOGY   (United States)

ⁱ UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^j UNIVERSITY OF WASHINGTON   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ARYLDIALKYLPHOSPHATASE; ARYLDIALKYLPHOSPHATASE 1; ARYLDIALKYLPHOSPHATASE 2; ARYLDIALKYLPHOSPHATASE 3; GENOMIC DNA; UNCLASSIFIED DRUG;

AMYOTROPHIC LATERAL SCLEROSIS; ARTICLE; GENE IDENTIFICATION; GENE MUTATION; GENETIC ANALYSIS; GENETIC VARIABILITY; HUMAN; LIPID OXIDATION; NONHUMAN; PRIORITY JOURNAL;

AMINO ACID SEQUENCE; AMYOTROPHIC LATERAL SCLEROSIS; ARYLDIALKYLPHOSPHATASE; DNA MUTATIONAL ANALYSIS; ESTERASES; FAMILY; HUMANS; MUTATION; SEQUENCE HOMOLOGY, AMINO ACID;

EID: 77954038587     PISSN: 03645134     EISSN: 15318249     Source Type: Journal    
DOI: 10.1002/ana.21993     Document Type: Article

References (25)

1. Costa LG, Vitalone A, Cole TB, Furlong CE. Modulation of paraoxonase (PON1) activity. Biochem Pharmacol 2005;69:541-550.
2. Sorenson RC, Bisgaier CL, Aviram M, et al. Human serum paraoxonase/arylesterase's retained hydrophobic N-terminal leader sequence associates with HDLs by binding phospholipids: apolipoprotein A-I stabilizes activity. Arterioscler Thromb Vasc Biol 1999;19:2214-2225.
3. Blatter MC, James RW, Messmer S, et al. Identification of a distinct human high-density lipoprotein subspecies defined by a lipoprotein-associated protein, K-45. Identity of K-45 with paraoxonase. Eur J Biochem 1993;211:871-879.
4. Draganov DI, Stetson PL, Watson CE, et al. Rabbit serum paraoxonase 3 (PON3) is a high density lipoprotein-associated lactonase and protects low density lipoprotein against oxidation. J Biol Chem 2000;275:33435-33442.
5. Ng CJ, Wadleigh DJ, Gangopadhyay A, et al. Paraoxonase-2 is a ubiquitously expressed protein with antioxidant properties and is capable of preventing cell-mediated oxidative modification of low density lipoprotein. J Biol Chem 2001;276:44444-44449. (Pubitemid 37391215)
6. Mackness MI, Arrol S, Durrington PN. Paraoxonase prevents accumulation of lipoperoxides in low-density lipoprotein. FEBS Lett 1991;286:152-154.
7. Draganov DI, Teiber JF, Speelman A, et al. Human paraoxonases (PON1, PON2, and PON3) are lactonases with overlapping and distinct substrate specificities. J Lipid Res 2005;46:1239-1247. (Pubitemid 43109838)
8. Landers JE, Shi L, Cho TJ, et al. A common haplotype within the PON1 promoter region is associated with sporadic ALS. Amyotroph Lateral Scler 2008;9:306-314.
9. Saeed M, Siddique N, Hung WY, et al. Paraoxonase cluster polymorphisms are associated with sporadic ALS. Neurology 2006;67:771-776. (Pubitemid 44394187)
10. Slowik A, Tomik B, Wolkow PP, et al. Paraoxonase gene polymorphisms and sporadic ALS. Neurology 2006;67:766-770. (Pubitemid 44394186)
11. Cronin S, Greenway MJ, Prehn JH, Hardiman O. Paraoxonase promoter and intronic variants modify risk of sporadic amyotrophic lateral sclerosis. J Neurol Neurosurg Psychiatry 2007;78:984-986.
12. Morahan JM, Yu B, Trent RJ, Pamphlett R. A gene-environment study of the paraoxonase 1 gene and pesticides in amyotrophic lateral sclerosis. Neurotoxicology 2007;28:532-540.
13. Valdmanis PN, Kabashi E, Dyck A, et al. Association of paraoxonase gene cluster polymorphisms with ALS in France, Quebec, and Sweden. Neurology 2008;71:514-520.
14. Wills AM, Cronin S, Slowik A, et al. A large-scale international meta-analysis of paraoxonase gene polymorphisms in sporadic ALS. Neurology 2009;73:16-24.
15. Josse D, Xie W, Renault F, et al. Identification of residues essential for human paraoxonase (PON1) arylesterase/organophosphatase activities. Biochemistry 1999;38:2816-2825.
16. Josse D, Ebel C, Stroebel D, et al. Oligomeric states of the detergent-solubilized human serum paraoxonase (PON1). J Biol Chem 2002;277:33386-33397.
17. Grimsley JK, Scholtz JM, Pace CN, Wild JR. Organophosphorus hydrolase is a remarkably stable enzyme that unfolds through a homodimeric intermediate. Biochemistry 1997;36:14366-14374.
18. Jarvik GP, Jampsa R, Richter RJ, et al. Novel paraoxonase (PON1) nonsense and missense mutations predicted by functional genomic assay of PON1 status. Pharmacogenetics 2003;13:291-295.
19. Bodmer W, Bonilla C. Common and rare variants in multifactorial susceptibility to common diseases. Nat Genet 2008;40:695-701.
20. Fearnhead NS, Wilding JL, Winney B, et al. Multiple rare variants in different genes account for multifactorial inherited susceptibility to colorectal adenomas. Proc Natl Acad Sci U S A 2004;101:15992-15997.
21. Fearnhead NS, Winney B, Bodmer WF. Rare variant hypothesis for multifactorial inheritance: susceptibility to colorectal adenomas as a model. Cell Cycle 2005;4:521-525. (Pubitemid 41359770)
22. Cohen JC, Kiss RS, Pertsemlidis A, et al. Multiple rare alleles contribute to low plasma levels of HDL cholesterol. Science 2004;305:869-872. (Pubitemid 39038422)
23. Shibata N, Nagai R, Uchida K, et al. Morphological evidence for lipid peroxidation and protein glycoxidation in spinal cords from sporadic amyotrophic lateral sclerosis patients. Brain Res 2001;917:97-104. (Pubitemid 32972133)
24. Ilieva EV, Ayala V, Jove M, et al. Oxidative and endoplasmic reticulum stress interplay in sporadic amyotrophic lateral sclerosis. Brain 2007;130:3111-3123. (Pubitemid 350209064)
25. Rainier S, Bui M, Mark E, et al. Neuropathy target esterase gene mutations cause motor neuron disease. Am J Hum Genet 2008;82:780-785.